.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020612

« Back to Dashboard
NDA 020612 describes LIDODERM, which is a drug marketed by Teikoku Pharma Usa and is included in one NDA. It is available from sixteen suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the LIDODERM profile page.

The generic ingredient in LIDODERM is lidocaine. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

Summary for NDA: 020612

Tradename:
LIDODERM
Applicant:
Teikoku Pharma Usa
Ingredient:
lidocaine
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 020612

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 020612

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDODERM
lidocaine
PATCH;TOPICAL 020612 NDA AUTHORIZED GENERIC Qualitest Pharmaceuticals 0603-1880 0603-1880-16 30 POUCH in 1 CARTON (0603-1880-16) > 1 PATCH in 1 POUCH (0603-1880-10)
LIDODERM
lidocaine
PATCH;TOPICAL 020612 NDA STAT RX USA LLC 16590-141 16590-141-30 30 PATCH in 1 CARTON (16590-141-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:PATCH;TOPICALStrength5%
Approval Date:Mar 19, 1999TE:ABRLD:Yes
Patent:5,827,529Patent Expiration:Oct 27, 2015Product Flag?Substance Flag?Delist Request?
Patented Use:EXTERNAL PREPARATION FOR APPLICATION TO THE SKIN CONTAINING LIDOCAINE-DRUG RETAINING LAYER PLACED ON SUPPORT AND COMPRISES ADHESIVE GEL BASE 1-10% BY WEIGHT OF LIDOCAINE

Expired Orange Book Patents for NDA: 020612

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,827,529► subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,411,738► subscribe
Teikoku Pharma Usa
LIDODERM
lidocaine
PATCH;TOPICAL020612-001Mar 19, 19995,601,838► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc